Constructive Bio appoints biopharma leader Jim Weissman to its Board of Directors
Constructive Bio, a leading synthetic biology company, today announces the appointment of Jim Weissman to its Board of Directors.
Constructive Bio shortlisted for One Nucleus Awards 2026: best use of emerging technology
Constructive Bio has been shortlisted for the One Nucleus Awards 2026 in the best use of emerging technology category for…
Constructive Bio’s 2025 Milestones in Non-Canonical Amino Acid (ncAA) Biomanufacturing
Constructive Bio’s 2025 achievements in non-canonical amino acid (ncAA) incorporation include expanded platform capabilities, new partnerships, and recognition from Nature…
Constructive Bio Licences tRNA Display Technology for Incorporating Non-Canonical Amino Acids into Peptides and Proteins
Constructive Bio has secured an exclusive licence for tRNA display technology, enabling directed integration of non-canonical amino acids (ncAAs) and…
